99 related articles for article (PubMed ID: 10570951)
21. Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex.
Sali DL; Ingram R; Wendel M; Gupta D; McNemar C; Tsarbopoulos A; Chen JW; Hong Z; Chase R; Risano C; Zhang R; Yao N; Kwong AD; Ramanathan L; Le HV; Weber PC
Biochemistry; 1998 Mar; 37(10):3392-401. PubMed ID: 9521660
[TBL] [Abstract][Full Text] [Related]
22. Processing of Japanese encephalitis virus non-structural proteins: NS2B-NS3 complex and heterologous proteases.
Jan LR; Yang CS; Trent DW; Falgout B; Lai CJ
J Gen Virol; 1995 Mar; 76 ( Pt 3)():573-80. PubMed ID: 7897348
[TBL] [Abstract][Full Text] [Related]
23. Internal cleavages of hepatitis C virus NS3 induced by P1 mutations at the NS3/4A cleavage site.
Hou X; Yang W; Zhao Y; Agarwal A; Huang M
Virology; 2009 Jan; 383(2):271-8. PubMed ID: 19036397
[TBL] [Abstract][Full Text] [Related]
24. Synthetic peptide inhibitors of complement serine proteases--I. Identification of functionally equivalent protease inhibitor sequences in serpins and inhibition of C1s and D.
Glover GI; Schasteen CS; Liu WS; Levine RP
Mol Immunol; 1988 Dec; 25(12):1261-7. PubMed ID: 3266291
[TBL] [Abstract][Full Text] [Related]
25. C1 Inhibitor as a glycoprotein: The influence of polysaccharides on its function and autoantibody target.
Ghannam A; Sellier P; Fain O; Martin L; Ponard D; Drouet C
Mol Immunol; 2016 Mar; 71():161-165. PubMed ID: 26897339
[TBL] [Abstract][Full Text] [Related]
26. Identification of the protease domain in NS3 of hepatitis C virus.
Han DS; Hahm B; Rho HM; Jang SK
J Gen Virol; 1995 Apr; 76 ( Pt 4)():985-93. PubMed ID: 9049347
[TBL] [Abstract][Full Text] [Related]
27. Expression of a hepatitis C virus NS3 protease-NS4A fusion protein in Escherichia coli.
Inoue H; Sakashita H; Shimizu Y; Yamaji K; Yokota T; Sudo K; Shigeta S; Shimotohno K
Biochem Biophys Res Commun; 1998 Apr; 245(2):478-82. PubMed ID: 9571178
[TBL] [Abstract][Full Text] [Related]
28. A high-throughput radiometric assay for hepatitis C virus NS3 protease.
Cerretani M; Di Renzo L; Serafini S; Vitelli A; Gennari N; Bianchi E; Pessi A; Urbani A; Colloca S; De Francesco R; Steinkühler C; Altamura S
Anal Biochem; 1999 Jan; 266(2):192-7. PubMed ID: 9888975
[TBL] [Abstract][Full Text] [Related]
29. Mechanistic role of an NS4A peptide cofactor with the truncated NS3 protease of hepatitis C virus: elucidation of the NS4A stimulatory effect via kinetic analysis and inhibitor mapping.
Landro JA; Raybuck SA; Luong YP; O'Malley ET; Harbeson SL; Morgenstern KA; Rao G; Livingston DJ
Biochemistry; 1997 Aug; 36(31):9340-8. PubMed ID: 9235976
[TBL] [Abstract][Full Text] [Related]
30. Establishment of a cell-based assay system for hepatitis C virus serine protease and its primary applications.
Mao HX; Lan SY; Hu YW; Xiang L; Yuan ZH
World J Gastroenterol; 2003 Nov; 9(11):2474-9. PubMed ID: 14606079
[TBL] [Abstract][Full Text] [Related]
31. Evolutionary dynamics of hepatitis C virus NS3 protease domain during and following treatment with narlaprevir, a potent NS3 protease inhibitor.
de Bruijne J; Thomas XV; Rebers SP; Weegink CJ; Treitel MA; Hughes E; Bergmann JF; de Knegt RJ; Janssen HL; Reesink HW; Molenkamp R; Schinkel J
J Viral Hepat; 2013 Nov; 20(11):779-89. PubMed ID: 24168257
[TBL] [Abstract][Full Text] [Related]
32. Proteolysis and deglycosylation of human C1 inhibitor. Effect on functional properties.
Reboul A; Prandini MH; Colomb MG
Biochem J; 1987 May; 244(1):117-21. PubMed ID: 3311024
[TBL] [Abstract][Full Text] [Related]
33. In trans interaction of hepatitis C virus helicase domains mediates protease activity critical for internal NS3 cleavage and cell transformation.
Pan RY; Hung TM; Kou YH; Chan NL; Chang MF; Chang SC
FEBS Lett; 2010 Feb; 584(3):482-6. PubMed ID: 19958771
[TBL] [Abstract][Full Text] [Related]
34. Structure and function of C1 inhibitor.
Davis AE
Behring Inst Mitt; 1989 Jul; (84):142-50. PubMed ID: 2679529
[TBL] [Abstract][Full Text] [Related]
35. Establishment and application of high throughput screening model for hepatitis C virus NS3-4A protease inhibitors in vitro.
Jian-rui L; Yan-bin W; Shu-yi S; Hong-shan C; Jian-dong J; Zong-gen B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Feb; 33(1):98-101. PubMed ID: 21375947
[TBL] [Abstract][Full Text] [Related]
36. Generation and characterization of a hepatitis C virus NS3 protease-dependent bovine viral diarrhea virus.
Lai VC; Zhong W; Skelton A; Ingravallo P; Vassilev V; Donis RO; Hong Z; Lau JY
J Virol; 2000 Jul; 74(14):6339-47. PubMed ID: 10864644
[TBL] [Abstract][Full Text] [Related]
37. Resistance profiling of hepatitis C virus protease inhibitors using full-length NS3.
Dahl G; Sandström A; Akerblom E; Danielson UH
Antivir Ther; 2007; 12(5):733-40. PubMed ID: 17713156
[TBL] [Abstract][Full Text] [Related]
38. Internal processing of hepatitis C virus NS3 protein.
Shoji I; Suzuki T; Sato M; Aizaki H; Chiba T; Matsuura Y; Miyamura T
Virology; 1999 Feb; 254(2):315-23. PubMed ID: 9986797
[TBL] [Abstract][Full Text] [Related]
39. HCV NS3 serine protease-neutralizing single-chain antibodies isolated by a novel genetic screen.
Gal-Tanamy M; Zemel R; Berdichevsky Y; Bachmatov L; Tur-Kaspa R; Benhar I
J Mol Biol; 2005 Apr; 347(5):991-1003. PubMed ID: 15784258
[TBL] [Abstract][Full Text] [Related]
40. Assessment of substrate specificity of hepatitis G virus NS3 protease by a genetic method.
Lee YJ; Kang H; Rho SH; Eom SH; Park WJ
Biochem Biophys Res Commun; 2001 Aug; 286(1):171-5. PubMed ID: 11485324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
